Development and Validation of Discriminative Dissolution Test for Tenofovir Disoproxil Fumarate Formulation
1, 1, 1, 1
- 1Department of Pharmaceutical Chemistry, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, INDIA.
CORRESPONDENCE
Dr. Krishna Gupta
Department of Pharmaceutical Chemistry, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee-441002, Nagpur, Maharashtra , INDIA.
Received: 26-04-2024; Revised: 03-11-2024; Accepted: 12-02-2025.
Volume 59, Issue 2 · pp. 628-638 · 2025 · DOI: 10.5530/ijper.20257094
ABSTRACT
Objectives and Introduction: This study uses HPLC and UV spectrophotometric methods to develop and validate a discriminative dissolution test method for quality control of tenofovir disoproxil fumarate in a tablet. Tenofovir disoproxil fumarate is a drug used in combination therapy to treat HIV infection. It has antiviral, prodrug, and HIV-1 reverse transcriptase inhibitory properties.Materials and Methods: Phosphate buffer 6.8, water, and 0.01 N HCl were the components of the discriminative solution. The USP Apparatus II blade should be used at 75 rpm and 900 mL of 0.01 N HCl at 37º±0.5ºC for the best dissolving. Tenofovir disoproxil fumarate's in vitro release profiles perform well under these circumstances. This was done on Agilent ZORBAX C8 a 6x150 mm column, the temperature of the column was ambient, its flow rate was 1.0 mL/ min and the detection wavelength was 260 nm. The mobile phase comprised of 70:30 v/v mixture of methanol and formic acid solution.Results: When the conditions were optimal, this approach demonstrated good release. Method validation was carried out as per the ICH guidelines. The drug follows zero-order release kinetics.Conclusion: The results obtained by the proposed method for dissolution test for Tenofovir disoproxil fumarate tablet formulation were found to be reliable, rugged, linear, accurate and precise.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Gupta, K., Ukey, A., Umap, A., & Umekar, M. (2025). Development and Validation of Discriminative Dissolution Test for Tenofovir Disoproxil Fumarate Formulation. Indian Journal of Pharmaceutical Education and Research, 59(2), 628-638. https://doi.org/10.5530/ijper.20257094
Copyright and licence
© 2025 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0